164 related articles for article (PubMed ID: 21622229)
1. Tissue factor and factor VIIa cross-species compatibility.
Knudsen T; Olsen OH; Petersen LC
Front Biosci (Landmark Ed); 2011 Jun; 16(9):3196-215. PubMed ID: 21622229
[TBL] [Abstract][Full Text] [Related]
2. Evolutionary conservation of the allosteric activation of factor VIIa by tissue factor in lamprey.
Beeler DL; Aird WC; Grant MA
J Thromb Haemost; 2018 Apr; 16(4):734-748. PubMed ID: 29418058
[TBL] [Abstract][Full Text] [Related]
3. Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study.
Petersen LC; Nørby PL; Branner S; Sørensen BB; Elm T; Stennicke HR; Persson E; Bjørn SE
Thromb Res; 2005; 116(1):75-85. PubMed ID: 15850611
[TBL] [Abstract][Full Text] [Related]
4. Structural biology of factor VIIa/tissue factor initiated coagulation.
Vadivel K; Bajaj SP
Front Biosci (Landmark Ed); 2012 Jun; 17(7):2476-94. PubMed ID: 22652793
[TBL] [Abstract][Full Text] [Related]
5. Substitution of the Gla domain in factor X with that of protein C impairs its interaction with factor VIIa/tissue factor: lack of comparable effect by similar substitution in factor IX.
Ndonwi M; Broze GJ; Agah S; Schmidt AE; Bajaj SP
J Biol Chem; 2007 May; 282(21):15632-44. PubMed ID: 17387172
[TBL] [Abstract][Full Text] [Related]
6. Allosteric activation of coagulation factor VIIa.
Persson E; Olsen OH
Front Biosci (Landmark Ed); 2011 Jun; 16(8):3156-63. PubMed ID: 21622226
[TBL] [Abstract][Full Text] [Related]
7. Characterization of canine coagulation factor VII and its complex formation with tissue factor: canine-human cross-species compatibility.
Knudsen T; Kristensen AT; Sørensen BB; Olsen OH; Stennicke HR; Petersen LC
J Thromb Haemost; 2010 Aug; 8(8):1763-72. PubMed ID: 20524980
[TBL] [Abstract][Full Text] [Related]
8. Structural modulation of factor VIIa by full-length tissue factor (TF
Prasad R; Sen P
J Biomol Struct Dyn; 2018 Feb; 36(3):621-633. PubMed ID: 28150568
[TBL] [Abstract][Full Text] [Related]
9. Molecular Basis of Enhanced Activity in Factor VIIa-Trypsin Variants Conveys Insights into Tissue Factor-mediated Allosteric Regulation of Factor VIIa Activity.
Sorensen AB; Madsen JJ; Svensson LA; Pedersen AA; Østergaard H; Overgaard MT; Olsen OH; Gandhi PS
J Biol Chem; 2016 Feb; 291(9):4671-83. PubMed ID: 26694616
[TBL] [Abstract][Full Text] [Related]
10. Engineering of substrate selectivity for tissue factor.factor VIIa complex signaling through protease-activated receptor 2.
Larsen KS; Ostergaard H; Olsen OH; Bjelke JR; Ruf W; Petersen LC
J Biol Chem; 2010 Jun; 285(26):19959-66. PubMed ID: 20388709
[TBL] [Abstract][Full Text] [Related]
11. Modulators of the coagulation cascade: focus and recent advances in inhibitors of tissue factor, factor VIIa and their complex.
Frédérick R; Pochet L; Charlier C; Masereel B
Curr Med Chem; 2005; 12(4):397-417. PubMed ID: 15720249
[TBL] [Abstract][Full Text] [Related]
12. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
Norledge BV; Petrovan RJ; Ruf W; Olson AJ
Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
[TBL] [Abstract][Full Text] [Related]
13. Molecular determinants involved in differential behaviour between soluble tissue factor and full-length tissue factor towards factor VIIa.
Prasad R; Sen P
Phys Chem Chem Phys; 2017 Aug; 19(33):22230-22242. PubMed ID: 28799584
[TBL] [Abstract][Full Text] [Related]
14. Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling.
Rothmeier AS; Liu E; Chakrabarty S; Disse J; Mueller BM; Østergaard H; Ruf W
Blood; 2018 Feb; 131(6):674-685. PubMed ID: 29246902
[TBL] [Abstract][Full Text] [Related]
15. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
[TBL] [Abstract][Full Text] [Related]
16. A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates.
Toso R; Pinotti M; High KA; Pollak ES; Bernardi F
Biochem J; 2002 Apr; 363(Pt 2):411-6. PubMed ID: 11931672
[TBL] [Abstract][Full Text] [Related]
17. Substitution of aspartic acid for methionine-306 in factor VIIa abolishes the allosteric linkage between the active site and the binding interface with tissue factor.
Persson E; Nielsen LS; Olsen OH
Biochemistry; 2001 Mar; 40(11):3251-6. PubMed ID: 11258943
[TBL] [Abstract][Full Text] [Related]
18. Sequential coagulation factor VIIa domain binding to tissue factor.
Osterlund M; Persson E; Carlsson U; Freskgård PO; Svensson M
Biochem Biophys Res Commun; 2005 Dec; 337(4):1276-82. PubMed ID: 16236263
[TBL] [Abstract][Full Text] [Related]
19. A thrombophilic allele of clotting Factor VII/VIIa promoting recurrent pulmonary emboli, clinical details, and a structural model of the altered protein: a case report.
Newman K; Daldal F; Dancis A
J Med Case Rep; 2023 Apr; 17(1):161. PubMed ID: 37055848
[TBL] [Abstract][Full Text] [Related]
20. Transition state analysis of the complex between coagulation factor VIIa and tissue factor: suggesting a sequential domain-binding pathway.
Osterlund M; Persson E; Svensson M; Carlsson U; Freskgård PO
Biochem Biophys Res Commun; 2005 Feb; 327(3):789-93. PubMed ID: 15649415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]